# The potential role and value of vitamin D in the treatment of tuberculosis

**Authors:** Meng Zeng, Jiyu Ran, Yun Luo, Xue Zhou, Yan Hu, Xiangyu Tian

PMC · DOI: 10.3389/fcimb.2025.1654860 · Frontiers in Cellular and Infection Microbiology · 2026-01-14

## TL;DR

This paper reviews how vitamin D may help boost the immune system to fight tuberculosis, a major global health issue.

## Contribution

The paper highlights vitamin D's potential as an immunomodulatory agent in tuberculosis treatment.

## Key findings

- Vitamin D is crucial for regulating the immune response against Mycobacterium tuberculosis.
- Many TB patients have low vitamin D levels, suggesting a link between deficiency and disease progression.
- Vitamin D could aid in developing new treatment strategies for TB.

## Abstract

Tuberculosis remains a prevalent and serious chronic bacterial infection worldwide. Despite significant advancements in TB treatment in recent years, it continues to pose a major public health challenge. The onset and progression of TB are closely associated with individuals who are immunocompromised, as most patients also present comorbidities such as HIV, diabetes mellitus, and nutritional deficiencies. Consequently, the development of new, non-toxic immunomodulatory drugs or treatment strategies may offer viable solutions to these issues. Vitamin D not only plays a crucial role in regulating calcium and phosphate metabolism while maintaining bone health but is also a key regulator of the innate immune response against microbial infections. Furthermore, many tuberculosis patients exhibit low levels of vitamin D; thus, vitamin D may represent an important resource for enhancing immune responses against Mycobacterium tuberculosis infections. This review discusses the immune response mechanisms, vitamin D synthesis processes, and metabolic pathways activated in hosts following infection with M. tuberculosis. It emphasizes how vitamin D contributes to immune regulation and its potential role in combating M. tuberculosis infections within the human body. This literature review aims to provide theoretical support for developing new drugs and treatment strategies for clinical management of anti-M. tuberculosis infections.

## Linked entities

- **Diseases:** tuberculosis (MONDO:0018076), diabetes mellitus (MONDO:0005015)
- **Species:** Mycobacterium tuberculosis (taxon 1773)

## Full-text entities

- **Diseases:** nutritional deficiencies (MESH:D044342), diabetes mellitus (MESH:D003920), bacterial infection (MESH:D001424), infection (MESH:D007239), microbial infections (MESH:D015163), M. tuberculosis infections (MESH:D014376), TB (MESH:D014390), HIV (MESH:D015658)
- **Chemicals:** phosphate (MESH:D010710), Vitamin D (MESH:D014807), calcium (MESH:D002118)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mycobacterium tuberculosis (species) [taxon 1773]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12847368/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12847368/full.md

## References

82 references — full list in the complete paper: https://tomesphere.com/paper/PMC12847368/full.md

---
Source: https://tomesphere.com/paper/PMC12847368